166 related articles for article (PubMed ID: 9891228)
1. Hot spots for molecular genetic alterations in lung cancer.
Pitterle DM; Jolicoeur EM; Bepler G
In Vivo; 1998; 12(6):643-58. PubMed ID: 9891228
[TBL] [Abstract][Full Text] [Related]
2. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
Li L; An Q; Feng X
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
4. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
6. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
Shuin T; Kamata M; Ashida S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
[TBL] [Abstract][Full Text] [Related]
7. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas.
Partridge M; Emilion G; Pateromichelakis S; Phillips E; Langdon J
Int J Cancer; 1999 Oct; 83(3):318-25. PubMed ID: 10495423
[TBL] [Abstract][Full Text] [Related]
8. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
9. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
10. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
11. Mouse models in tumor suppression.
Ghebranious N; Donehower LA
Oncogene; 1998 Dec; 17(25):3385-400. PubMed ID: 9917000
[TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
[TBL] [Abstract][Full Text] [Related]
13. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
14. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues.
Petursdottir TE; Thorsteinsdottir U; Jonasson JG; Moller PH; Huiping C; Bjornsson J; Egilsson V; Imreh S; Ingvarsson S
Genes Chromosomes Cancer; 2004 Nov; 41(3):232-42. PubMed ID: 15334546
[TBL] [Abstract][Full Text] [Related]
15. Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas.
Miyakis S; Liloglou T; Kearney S; Xinarianos G; Spandidos DA; Field JK
Lung Cancer; 2003 Mar; 39(3):273-7. PubMed ID: 12609565
[TBL] [Abstract][Full Text] [Related]
16. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.
Moore PS; Zamboni G; Brighenti A; Lissandrini D; Antonello D; Capelli P; Rigaud G; Falconi M; Scarpa A
Am J Pathol; 2001 Jan; 158(1):317-21. PubMed ID: 11141506
[TBL] [Abstract][Full Text] [Related]
18. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
19. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
Sakata K
J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]